Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

735.20
+0.39000.05%
Post-market: 737.802.60+0.35%17:29 EDT
Volume:613.94K
Turnover:451.26M
Market Cap:75.69B
PE:18.18
High:742.50
Open:740.50
Low:729.20
Close:734.81
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.69
T/O Rate:0.62%
Dividend:3.64
Dividend Rate:0.50%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.39
PE(LYR):17.72

Loading ...

Sanofi - and Regeneron Settle Prior Collaboration-Related Litigation

THOMSON REUTERS
·
Oct 01

Sanofi - Regeneron May Include Sanofi's Lunsekimig Therapy After Phase 3 Studies

THOMSON REUTERS
·
Oct 01

Sanofi - Regeneron to Receive $1 Bln Upfront with Potential for up to an Additional $7 Bln in Future Milestone Payments

THOMSON REUTERS
·
Oct 01

The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind

Dow Jones
·
Oct 01

Regeneron Drug Halves Muscle Loss in Combination with Novo's Semaglutide in Trial

Reuters
·
Oct 01

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 01

Regeneron Links 2026 CEO, CSO PSU Awards to FDA Filings, Approvals and New-Product Revenue Targets Through 2035

Reuters
·
Oct 01

Regeneron’s ALN-F1202 Safety Trial Marks a Quiet but Important Pipeline Milestone

TIPRANKS
·
Oct 01

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Dow Jones
·
Sep 30

Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says

MT Newswires Live
·
Sep 30

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

TIPRANKS
·
Sep 29

Court Dismisses Regeneron Pharmaceuticals (REGN) Securities Lawsuit Over Eylea and Eylea HD Claims

TIPRANKS
·
Sep 29

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)

TIPRANKS
·
Sep 29

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

Regeneron Pharmaceuticals Inc. Stock Falls 4.5%, Underperforms Peers

Dow Jones
·
Sep 29

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

Reuters
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

TIPRANKS
·
Sep 29

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Dow Jones
·
Sep 28

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28